Can a tiny implant trap brain tumor cells and make radiation work better?

NCT ID NCT07725640

First seen Jul 24, 2026 · Last updated Jul 24, 2026

Summary

This pilot trial is testing a medical device called GlioHook, which is implanted in the brain after surgery to remove a high-grade glioma. The implant is designed to trap any remaining tumor cells and make follow-up radiotherapy more effective. The study includes about 15 adults with suspected high-grade glioma and will focus on safety and how long the disease stays under control.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a medical implant called GlioHook, placed after tumor removal to trap cancer cells and make radiotherapy more effective
What this could lead to
If successful, this implant could offer a new way to prevent glioma recurrence and improve the effectiveness of standard radiotherapy.
What could go wrong
This is a very early pilot study with only 15 participants, so results may not apply broadly. The implant carries risks of infection, inflammation, or need for removal.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Complejo Hospitalario Universitario de Santiago

    Santiago de Compostela, Spain

    Contact

    Contact

  • Hospital HM Sanchinarro

    Madrid, Spain

    Contact

    Contact

  • Hospital Universitario Vall d'Hebron

    Barcelona, Spain

    Contact

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.